RecruitingNCT03047369
Rare condition
Allan-Herndon-Dudley syndrome
3
studies recruiting now
as of 7 Sept 2026
11
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
22 Aug 2024
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06566066
Register for Patients With Thyroid Hormone Resistance.
RecruitingNCT04463316
GROWing Up With Rare GENEtic Syndromes
Showing the 3 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Allan-Herndon-Dudley syndrome studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Allan-Herndon-Dudley syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Allan-Herndon-Dudley syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (SLC16A2).
Treatments being studied
2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Tiratricol
Phase 2/3Glycerol Phenylbutyrate (Ravicti)
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).